亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Allogeneic Stem Cell Therapy for Acute Ischemic Stroke

医学 改良兰金量表 冲程(发动机) 内科学 安慰剂 临床试验 中风恢复 物理疗法 缺血 缺血性中风 病理 康复 机械工程 替代医学 工程类
作者
Kiyohiro Houkin,Toshiya Osanai,Shinichiro Uchiyama,Kazuo Minematsu,Akihiko Taguchi,Katsuhiko Maruichi,Yoshimasa Niiya,Katsuyuki Asaoka,Yoshihiro Kuga,Katsumi Takizawa,Koichi Haraguchi,Shinichi Yoshimura,Kazumi Kimura,Koji Tokunaga,Atsuo Aoyama,Fusao Ikawa,Chikanori Inenaga,Tatsuya Abé,Atsushi Tominaga,Shinichi Takahashi
出处
期刊:JAMA Neurology [American Medical Association]
被引量:18
标识
DOI:10.1001/jamaneurol.2023.5200
摘要

Importance Cell therapy is a promising treatment approach for stroke and other diseases. However, it is unknown whether MultiStem (HLCM051), a bone marrow–derived, allogeneic, multipotent adult progenitor cell product, has the potential to treat ischemic stroke. Objective To assess the efficacy and safety of MultiStem when administered within 18 to 36 hours of ischemic stroke onset. Design, Setting, and Participants The Treatment Evaluation of Acute Stroke Using Regenerative Cells (TREASURE) multicenter, double-blind, parallel-group, placebo-controlled phase 2/3 randomized clinical trial was conducted at 44 academic and clinical centers in Japan between November 15, 2017, and March 29, 2022. Inclusion criteria were age 20 years or older, presence of acute ischemic stroke (National Institutes of Health Stroke Scale [NIHSS] score of 8-20 at baseline), confirmed acute infarction involving the cerebral cortex and measuring more than 2 cm on the major axis (determined with diffusion-weighted magnetic resonance imaging), and a modified Rankin Scale (mRS) score of 0 or 1 before stroke onset. Data analysis was performed between May 9 and August 15, 2022. Exposure Patients were randomly assigned to either intravenous MultiStem in 1 single unit of 1.2 billion cells or intravenous placebo within 18 to 36 hours of ischemic stroke onset. Main Outcomes and Measures The primary end points were safety and excellent outcome at day 90, measured as a composite of a modified Rankin Scale (mRS) score of 1 or less, a NIHSS score of 1 or less, and a Barthel index score of 95 or greater. The secondary end points were excellent outcome at day 365, mRS score distribution at days 90 and 365, and mRS score of 0 to 1 and 0 to 2 at day 90. Statistical analysis of efficacy was performed using the Cochran-Mantel-Haenszel test. Results This study included 206 patients (104 received MultiStem and 102 received placebo). Their mean age was 76.5 (range, 35-95) years, and more than half of patients were men (112 [54.4%]). There were no between-group differences in primary and secondary end points. The proportion of excellent outcomes at day 90 did not differ significantly between the MultiStem and placebo groups (12 [11.5%] vs 10 [9.8%], P = .90; adjusted risk difference, 0.5% [95% CI, −7.3% to 8.3%]). The frequency of adverse events was similar between treatment groups. Conclusions and Relevance In this randomized clinical trial, intravenous administration of allogeneic cell therapy within 18 to 36 hours of ischemic stroke onset was safe but did not improve short-term outcomes. Further research is needed to determine whether MultiStem therapy for ischemic stroke has a beneficial effect in patients who meet specific criteria, as indicated by the exploratory analyses in this study. Trial Registration ClinicalTrials.gov Identifier: NCT02961504
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S应助科研通管家采纳,获得10
23秒前
木木完成签到 ,获得积分10
27秒前
34秒前
董可以发布了新的文献求助10
38秒前
小马甲应助董可以采纳,获得10
46秒前
1分钟前
Boren发布了新的文献求助10
1分钟前
梨子完成签到,获得积分10
1分钟前
Boren完成签到,获得积分10
1分钟前
WerWu完成签到,获得积分10
2分钟前
彭于晏应助Dc采纳,获得10
3分钟前
4分钟前
情怀应助科研通管家采纳,获得10
4分钟前
5分钟前
Dc发布了新的文献求助10
5分钟前
Dc完成签到,获得积分10
5分钟前
5分钟前
幽默平安发布了新的文献求助10
5分钟前
科研通AI2S应助科研通管家采纳,获得10
6分钟前
7分钟前
7分钟前
7分钟前
小禾一定行完成签到 ,获得积分10
7分钟前
inkoin发布了新的文献求助10
7分钟前
科研通AI2S应助科研通管家采纳,获得10
8分钟前
inkoin完成签到,获得积分10
8分钟前
8分钟前
积极的台灯应助Akitten采纳,获得10
8分钟前
隐形曼青应助务实书包采纳,获得10
9分钟前
9分钟前
9分钟前
爱思考的小笨笨完成签到,获得积分10
10分钟前
GingerF应助科研通管家采纳,获得50
10分钟前
GingerF应助科研通管家采纳,获得50
10分钟前
上官若男应助闫雪采纳,获得10
10分钟前
10分钟前
10分钟前
Akitten发布了新的文献求助10
11分钟前
11分钟前
大写的LV完成签到 ,获得积分10
11分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990290
求助须知:如何正确求助?哪些是违规求助? 3532146
关于积分的说明 11256472
捐赠科研通 3271042
什么是DOI,文献DOI怎么找? 1805197
邀请新用户注册赠送积分活动 882302
科研通“疑难数据库(出版商)”最低求助积分说明 809234